tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market
Advertisement

Zelira Therapeutics (ZLDAF) Financial Statements

Compare
16 Followers

Zelira Therapeutics Financial Overview

Zelira Therapeutics's market cap is currently $2.97M. The company's EPS TTM is $-0.06794267999999999; its P/E ratio is ―; Zelira Therapeutics is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

Zelira Therapeutics Debt to Assets

Zelira Therapeutics Cash Flow

Zelira Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis